3.73

1.36% 0.05

Maravai Lifesciences Holdings Inc (MRVI)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt MRVI? Forum Prognose

Schlusskurs vom Vortag:

$3.68

Offen:

$3.7

24-Stunden-Volumen:

871.85K

Relative Volume:

0.55

Marktkapitalisierung:

$550.16M

Einnahmen:

$185.74M

Nettoeinkommen (Verlust:

$-230.76M

KGV:

-4.1175

EPS:

-0.9059

Netto-Cashflow:

$-70.72M

1W Leistung:

+5.07%

1M Leistung:

+29.97%

6M Leistung:

+18.79%

1J Leistung:

+83.74%

1-Tages-Spanne:

$3.66

$3.765

1-Wochen-Bereich:

$3.47

$3.765

52-Wochen-Spanne:

$1.95

$4.105

Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile

Firmenname

Maravai Lifesciences Holdings Inc

Sektor

Healthcare (1112)

Branche

Biotechnology (622)

Telefon

(858) 546-0004

Adresse

10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO

Mitarbeiter

435

Twitter

Nächster Verdiensttermin

2026-05-07

Neueste SEC-Einreichungen

MRVI's Discussions on Twitter

Compare MRVI vs VRTX, REGN, ARGX, ALNY, ONC

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
MRVI Maravai Lifesciences Holdings Inc	3.73	550.16M	185.74M	-230.76M	-70.72M	-0.9059
VRTX Vertex Pharmaceuticals Inc	423.92	107.83B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	701.42	73.54B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	783.50	48.72B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	296.11	39.51B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	293.86	32.66B	5.36B	287.73M	924.18M	2.5229

Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-02-26	Herabstufung	Robert W. Baird	Outperform → Neutral
2024-12-19	Eingeleitet	Guggenheim	Neutral
2024-12-05	Herabstufung	Goldman	Neutral → Sell
2024-11-14	Eingeleitet	Wolfe Research	Peer Perform
2024-11-08	Herabstufung	William Blair	Outperform → Mkt Perform
2024-08-28	Eingeleitet	Wells Fargo	Overweight
2024-08-13	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2024-04-10	Eingeleitet	Craig Hallum	Buy
2023-12-12	Hochstufung	BofA Securities	Neutral → Buy
2023-08-08	Herabstufung	KeyBanc Capital Markets	Overweight → Sector Weight
2023-05-23	Herabstufung	Credit Suisse	Outperform → Neutral
2023-05-09	Herabstufung	Goldman	Buy → Neutral
2023-01-05	Herabstufung	UBS	Buy → Neutral
2022-12-14	Eingeleitet	Deutsche Bank	Buy
2022-12-07	Eingeleitet	RBC Capital Mkts	Outperform
2022-11-03	Herabstufung	BofA Securities	Buy → Neutral
2022-08-25	Eingeleitet	Credit Suisse	Outperform
2021-08-05	Fortgesetzt	Credit Suisse	Outperform
2020-12-16	Eingeleitet	KeyBanc Capital Markets	Overweight
2020-12-15	Eingeleitet	BofA Securities	Buy
2020-12-15	Eingeleitet	Credit Suisse	Outperform
2020-12-15	Eingeleitet	Goldman	Buy
2020-12-15	Eingeleitet	Jefferies	Buy
2020-12-15	Eingeleitet	Robert W. Baird	Outperform
2020-12-15	Eingeleitet	Stifel	Buy
2020-12-15	Eingeleitet	William Blair	Outperform
2020-12-14	Eingeleitet	UBS	Buy

Alle ansehen

Maravai Lifesciences Holdings Inc Aktie (MRVI) Neueste Nachrichten

May 01, 2026

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Recommendation of "Hold" by Brokerages - MarketBeat

May 01, 2026

Apr 30, 2026

Maravai LifeSciences (MRVI) Expected to Announce Earnings on Thursday - MarketBeat

Apr 30, 2026

Maravai LifeSciences Sees Unusually High Options Volume (NASDAQ:MRVI) - MarketBeat

Apr 30, 2026

Apr 27, 2026

What management guidance Maravai (MRVI)? (-0.14%) 2026-04-27Risk Analysis - Newser

Apr 27, 2026

Apr 24, 2026

[ARS] MARAVAI LIFESCIENCES HOLDINGS, INC. SEC Filing - Stock Titan

Apr 24, 2026

Maravai (MRVI) sets 2026 virtual meeting, board elections and say-on-pay - Stock Titan

Apr 24, 2026

Apr 20, 2026

Maravai LifeSciences To Host Earnings Conference Call on Thursday, May 7, 2026 - The National Law Review

Apr 20, 2026

Press Release: Maravai LifeSciences To Host Earnings Conference Call on Thursday, May 7, 2026 - Moomoo

Apr 20, 2026

Apr 17, 2026

Maravai LifeSciences Holdings (MRVI) Stock Analysis: A Closer Look at a 34.90% Potential Upside - DirectorsTalk Interviews

Apr 17, 2026

Apr 16, 2026

Investors Purchase Large Volume of Maravai LifeSciences Put Options (NASDAQ:MRVI) - MarketBeat

Apr 16, 2026

Apr 14, 2026

Maravai LifeSciences (NASDAQ:MRVI) Sees Strong Trading VolumeTime to Buy? - MarketBeat

Apr 14, 2026

Maravai LifeSciences (MRVI) Carrying Moderately Bullish Sentiment Despite Options-Linked Volatility - Insider Monkey

Apr 14, 2026

Apr 13, 2026

8 Best Life Sciences Penny Stocks to Buy - Insider Monkey

Apr 13, 2026

VIX Spike: Will Maravai LifeSciences Holdings Inc stock hit new highs in YEAR2026 Key Highlights & Smart Investment Allocation Insights - baoquankhu1.vn

Apr 13, 2026

How Maravai LifeSciences (MRVI) Q4 Results Are Shaping A Cautious Valuation Narrative - Yahoo Finance

Apr 13, 2026

Is Maravai (MRVI) Stock Stronger Than Peers | Price at $3.06, Down 0.33%Support Bounce - Newser

Apr 13, 2026

Apr 12, 2026

Chart Watch: Will Maravai LifeSciences Holdings Inc stock hit new highs in YEAR2026 Market WrapUp & AI Based Trade Execution Alerts - baoquankhu1.vn

Apr 12, 2026

Apr 08, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

Apr 08, 2026

Is Maravai (MRVI) Stock Priced Correctly | Price at $3.17, Up 9.86%Expert Momentum Signals - Xã Vĩnh Công

Apr 08, 2026

Apr 07, 2026

Gainers Report: How does Maravai LifeSciences Holdings Inc score in quality rankingsProfit Target & Long Hold Capital Preservation Plans - baoquankhu1.vn

Apr 07, 2026

Apr 06, 2026